Systems Biology of Early Atopy (SUNBEAM Trial)
Palo Alto (17 mi)Age: Any Age
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Recruiting
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
No Placebo Group
Trial Summary
What is the purpose of this trial?The goal of this study is to establish a birth cohort that collects prenatal and early life biosamples and environmental samples and rigorously phenotypes young children for food allergy and Atopic Dermatitis (AD) to identify prenatal and early life markers of high risk for food allergy and AD, as well as biological pathways (endotypes) that result in these conditions.
Primary Objectives:
* To study the role and interrelationships of established and novel clinical, environmental, biological, and genetic prenatal and early-life factors in the development of allergic diseases through age 3 years, with an emphasis on atopic dermatitis and food allergy
* To apply systems biology to identify mechanisms and biomarkers underlying the development of food allergy, atopic dermatitis, and their endotypes
* To collect, process, and assay or store environmental and biological samples for current and future use in the study of allergic disease development
Eligibility Criteria
Treatment Details
Find a clinic near you
Research locations nearbySelect from list below to view details:
Henry Ford Health System, Division of Allergy and ImmunologyDetroit, MI
Johns Hopkins Children's Center, Department of Allergy & ImmunologyBaltimore, MD
Arkansas Children's HospitalLittle Rock, AR
Kravis Children's Hospital, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount SinaiNew York, NY
More Trial Locations
Loading ...
Who is running the clinical trial?
National Institute of Allergy and Infectious Diseases (NIAID)Lead Sponsor
Consortium for Food Allergy ResearchCollaborator
Rho Federal Systems Division, Inc.Industry Sponsor